NemaLife Inc is a developer of a large-scale technology for whole-life studies intended to identify molecules that promote healthy human life. The company's screening technology harnesses the power of microfluidics, automation, computer vision and data-driven intelligence to deliver insights on animal healthspan, behavior and survival at an unprecedented pace, enabling biotechnologists to prioritize costly drug studies in mammalian models and unleashing new genetic targets and drugs for improving quality of life.
